Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) versus bendamustine and Rituximab (BR) in previously untreated and physically fit patients (pts) with advanced chronic lymphocytic Leukemia (CLL): Results of a planned interim analysis of the cll10 trial, an international, randomized study of the German CLL study group (GCLLSG)

Authors
Category Primary study
JournalBlood
Year 2013
This article has no abstract
Epistemonikos ID: f5879dcf415e6ec2033949b382fda7b106f2be55
First added on: Oct 13, 2018